IROS and partners use Emirati Genome Programme to identify high-risk individuals before symptoms appear
Author: Clinical Editor
Company secures first commercial product with data for active and chronic TED
Updated Date: Fri, 19 Jun 2026 00:00:00 EDT
Updated Date: Fri, 19 Jun 2026 00:00:00 EDT
Updated Date: Fri, 19 Jun 2026 00:00:00 EDT
Updated Date: Fri, 19 Jun 2026 00:00:00 EDT
Updated Date: Fri, 19 Jun 2026 00:00:00 EDT
Updated Date: Thu, 18 Jun 2026 00:00:00 EDT
Researchers found that a rare liver cancer evades immunotherapy by luring immune T cells away from the tumor […]
No adverse events observed as study begins in EGFR‑mutant NSCLC